Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Senior Market Sales Acquires New Jersey-Based Medi-Solutions Insurance Agency
Senior Market Sales (SMS) announced that it has acquired Medi-Solutions Insurance Agency, LLC, a provider of Medicare insurance plans to clients nationally. Medi-Solutions Insurance serves clients in New Jersey as First Jersey Insurance Agency, which opened in 1985. Starting in 1989, the business grew to provide Medicare plans in New Jersey, New York and Connecticut. In 2018, the company expanded with Medi-Solutions, which sells Medicare in New Jersey, Florida and throughout the United States. Founded in 1982, SMS is headquartered in Omaha, Nebraska. SMS represents top Medicare Supplement, Medicare Advantage, annuity, life, long-term care and travel insurance carriers in all 50... Read More »
TREND Health Partners Acquires Advent Health Partners
TREND Health Partners, an independent healthcare payment integrity company, announced on December 15 that it has acquired Advent Health Partners, Inc. This strategic combination solidifies TREND’s position as a leading AI-driven payment accuracy and revenue integrity platform for healthcare payers and providers. The combined company will serve more than 50 health plans and nearly 1,000 hospitals. Based in Nashville, Tennessee, Advent Health Partners provides health systems and hospitals with revenue optimization plans to solve their financial problems. The company has developed CAVO®, its proprietary technology platform, which uses artificial intelligence to streamline the review of... Read More »
Veranex Acquires Atlanta-Based CRO T3 Labs
Veranex announced that it has acquired T3 Labs for an undisclosed price. T3 Labs is a contract research organization (CRO) in Atlanta offering preclinical testing services. The company brings devices, drugs and biologics from concept to commercialization. Founded in 2021, Veranex is a comprehensive, global, tech-enabled service provider dedicated to the MedTech industry. Offering expert guidance from concept to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation and accelerated market viability assessment. Veranex is backed by Summit Partners, Accelmed and Lauxera Capital... Read More »
Schweiger Dermatology Group Acquires Two New Jersey Practices
NavaDerm Partners, LLC, a portfolio company of BelHealth Investment Partners, LLC announced that it was selling two of its New Jersey practices to Schweiger Dermatology Group (SDG). The practices are Millburn Laser Center and Scherl Dermatology. Millburn Laser Center provides dermatology care out of one location in New Jersey. According to its website, the practice has five providers on staff. Scherl Dermatology is a four-physician practice that operates out of one location in Englewood Cliffs, New Jersey. Founded in 2010, SDG is the largest group dermatology practice in the Northeast, with more than 90 offices and more than 300 healthcare providers in its... Read More »
HCRG Care Group Acquires Operose Health
On December 13, it was announced that Centene Cooperation was selling Operose Health to HCRG Care Group for an undisclosed price. Operose Health is a network of nearly 60 primary care practices across the United Kingdom. The company has been a significant player in the NHS primary care market, providing essential healthcare services to numerous patients. Previously known as Virgin Care, HCRG Care Group is one of the United Kingdom’s largest providers of community health and care services. It partners with the NHS to provide primary and dermatological care as well as pathway and diagnostic services. The deal is expected to impact the operational landscape of... Read More »
Lutheran Senior Services to Acquire St. Louis Home Health
Lutheran Senior Services (LSS) announced that it has signed a definitive agreement to acquire St. Louis Home Health. According to data captured in the LevinPro HC database, this acquisition represents the 92nd Home Health & Hospice transaction of 2023. St. Louis Home Health is a specialized and highly personalized home health agency serving 3,500 patients annually in Missouri and Illinois. The company has been operating for more than 25 years and is particularly trusted by Orthopedists. LSS is a not-for-profit network that specializes in housing, care and supportive services for older adults 60 years and older. With 18 locations in Missouri and Illinois, LSS serves more... Read More »
Healthcare Download with VMG Health: A Conversation Led by Jen Johnson and Greg Koonsman
In a recent episode of “Healthcare Download with VMG Health”, Jen Johnson, COO and Managing Director of VMG Health, sat down with Greg Koonsman, CEO and Founder, to discuss private equity in healthcare. In the podcast, Koonsman and Johnson explore the increasing flow of capital and the emerging pattern of strategic collaborations between private equity (PE) firms and health systems. Additionally, they address possible activity in 2024 and delve into the projected surge in groundbreaking partnerships. They underscore the potential of these collaborations to boost growth, facilitate access to capital, and improve the overall quality of healthcare services. Key points from the... Read More »
Navigating Digital Health in 2024: Insights from Rock Health
Rock Health’s “Digital Health at the Turn of 2024” report sheds light on trends shaping the trajectory of the healthcare industry in 2024. Drawing observations from an in-depth analysis of research, funding and partnerships, the report identifies noteworthy developments gaining momentum and facing challenges. AI in Healthcare and Value-Based Care Enablement: While AI in healthcare and value-based care enablement stand as burgeoning trends, the report highlights a current limitation in scalability. The authors emphasize crucial considerations for AI builders, addressing concerns such as algorithm bias and ethical implications. For stakeholders like providers, payers... Read More »
AstraZeneca Picks up Vaccine Developer Icosavax for $800 Million
AstraZeneca announced on December 12 that it is acquiring Icosavax, which develops a shot for respiratory syncytial virus (RSV), for $800 million in upfront cash. The deal value equates to $15 per share. Icosavax’s shareholders will also be in line for another $5 in cash per share, if certain regulatory and sale milestones are hit. Icosavax is a clinical-stage biopharmaceutical company leveraging its virus-like particles (VLPs) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases and a vision for combination and pan-respiratory vaccines. The company’s pipeline includes a phase 3-ready protein VLP... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
